⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.
Myokines as Sarcopenia Biomarkers
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-15 — Chronic kidney disease-stratified plasma proteomic signatures of probable sarcopenia: A UK biobank cohort study.: cross-connection with omics-aging-signatures: COL6A3/GDF15-led UK Biobank proteomic signature links the general plasma proteomic-aging layer to the muscle-specific biomarker catalog for sarcopenia, with CKD amplifying the association. (novelty: 3)
- 2026-09-16 — Cross-organ crosstalk in brain-aging-related sarcopenia: Caudate iron accumulation impairs muscle health via blood-brain barrier dysfunction.: cross-connection with brain-mri-biological-age: Plasma TYRO3 emerges as a mediating circulating protein between brain iron accumulation and muscle phenotype, adding a BBB-linked candidate to the muscle-signaling biomarker set. (novelty: 3)
Open questions
Related
Contributing findings
Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
14-jul-2026
novelty 2
per-area 2
introduces